Hematologic Cancer

ARUP offers a comprehensive array of over 60 tests in the area of hematopathology including flow cytometry, molecular diagnostics, immunohistochemistry, cytogenetics and fluorescence in situ hybridization (FISH). Among the molecular tests currently offered are FLT-3, NPM-1, CEBPA, WT1, MPL, JAK2 (V617F), JAK2 (exon 12), IDH1/2, KIT, PML-RARA and BCR-ABL1 kinase. In addition, quantitative PCR testing is available for PML-RARA and BCR-ABL1 (p190 and p210). Extensive FISH testing, for both fresh and fixed specimens, is available to aid in the diagnosis and prognostication of numerous myeloid and lymphoid neoplasms. An expanded menu of immunohistochemical stains is offered by ARUP with “stain and return” service. Flow cytometry services including interpretation and consultation integration are also available.
  • Medical Director, Hematopathology and Special Genetics
    Dr. Agarwal is an associate professor of pathology at the University of Utah School of Medicine. She received her MD at Delhi University in India and was a postdoctoral research scholar at the University of Iowa. She served as a pathology resident, a hematopathology fellow, and a molecular genetics pathology fellow at the University of Utah School of Medicine. Dr. Agarwal is board certified in hematopathology, anatomic pathology, and clinical pathology. She is also a member of several professional societies, including the College of American Pathologists and the American Society for Clinical Pathology. Dr. Agarwal’s research interests include red-cell enzymopathies, hemoglobinopathies, and molecular hematopathology.
  • Medical Director, Hematopathology
    Dr. Bahler is an associate professor of pathology at the University of Utah School of Medicine. He is certified by the American Board of Pathology in clinical pathology, with an added qualification in hematology. Dr. Bahler received his PhD in immunology and his MD from the University of Rochester. His research interests include the role of antigen receptor stimulation in the development of lymphoid malignancies.
  • Medical Director, Cytogenetics and Genomic Microarray
    Dr. Hong is an assistant professor of pathology at University of Utah School of Medicine. She received her MD at Beijing Medical University in Beijing, China, and completed her residency in internal medicine and hematology at People’s Hospital, Beijing Medical University, and fellowship in clinical cytogenetics at the University of Utah. She is board certified by the American Board of Medical Genetics and Genomics and is a fellow of the American College of Medical Genetics and Genomics. Her academic interests include cytogenetic profile of hematologic malignancies, particularly childhood leukemia.
  • Section Chief, Hematopathology
    Medical Director, Hematologic Flow Cytometry
    Medical Director, Immunohistochemistry Laboratory
    Medical Director, Histology Laboratory
    Dr. Miles is an associate professor of pathology at the University of Utah School of Medicine. He received his MD and a PhD in cell biology from the University of Nebraska and is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty certification in hematology. His research interests include biological subtypes of adult and pediatric non-Hodgkin lymphomas. Dr. Miles is a member the American Society of Hematology, the Society for Hematopathology, and the United States and Canadian Academy of Pathology.
  • Chief Executive Officer, ARUP Laboratories
    Dr. Perkins is the CEO of ARUP Laboratories and a professor of pathology at the University of Utah School of Medicine. Dr. Perkins has been with ARUP and the University of Utah for over 25 years. During this time, she has served in numerous leadership roles, including director of hematopathology, interim department chair, division chief of clinical pathology, director of the ARUP R&D Institute, and, for the past 10 years, member of the ARUP Laboratories' executive management team. She is a tenured professor at the University of Utah School of Medicine, is board certified in anatomic pathology, and holds a special qualification in hematology. She has authored over 200 peer-reviewed journal articles and 70 book chapters in hematopathology. She received her PhD in biochemistry from the University of Miami, and earned her MD and completed her pathology residency at Washington University in St. Louis. She completed her hematopathology fellowship under Dr. Carl Kjeldsberg at the University of Utah.
  • Medical Director, Hemostasis/Thrombosis
    Dr. Rodgers is a professor of medicine and pathology at the University of Utah School of Medicine. He received his PhD in pharmacology and his MD from the Tulane University School of Medicine and is certified in internal medicine by the American Board of Internal Medicine and in hematology by the American Board of Pathology. Dr. Rodgers is the co-editor of Wintrobe’s Clinical Hematology.
  • Medical Director, Hemostasis/Thrombosis Laboratory
    Dr. Smock is an associate professor of pathology and associate program director of the Pathology Residency Program at the University of Utah School of Medicine. She completed her medical degree, residency, and fellowship training at the University of Utah and is board certified in anatomic and clinical pathology, as well as hematopathology. In addition to serving as medical director of the Hemostasis/Thrombosis Laboratory at ARUP, she is an active member of several professional organizations and national committees in this area. She is currently vice president of the North American Specialized Coagulation Laboratory Association (NASCOLA) and a member of the College of American Pathologists Coagulation Resource Committee and the National Comprehensive Cancer Network Clinical Practice Guidelines Panel for Cancer-Associated Venous Thromboembolic Disease. She is also an editorial board member for Research and Practice in Thrombosis and Haemostasis. Dr. Smock’s primary research interest is laboratory coagulation medicine.